John T Wilkins, MD (@jtwilkinsmd) 's Twitter Profile
John T Wilkins, MD

@jtwilkinsmd

Associate Professor of Cardiology and Preventive Medicine @NorthwesternMed @NMCardioVasc
Tweets are my own & RT do not = endorsements

ID: 1370132287560486912

calendar_today11-03-2021 22:00:54

20 Tweet

230 Followers

253 Following

Neil Stone (@nstonedoc) 's Twitter Profile Photo

Tracking Residual Risk: Time for a Change? ∗ jacc.org/doi/10.1016/j.…. Editorial provides perspective on insightful article just published in JACC.

John T Wilkins, MD (@jtwilkinsmd) 's Twitter Profile Photo

#Proteoform level characterization of human apolipoproteins will improve insight into the complex pathways through which proteins signify and mediate cardiometabolic health and disease. #cardiotwitter #prevention #cardiology Don Lloyd-Jones Neil Kelleher ahajournals.org/doi/10.1161/JA…

#Proteoform level characterization of human apolipoproteins will improve insight into the complex pathways through which proteins signify and mediate cardiometabolic health and disease. #cardiotwitter #prevention #cardiology <a href="/dmljmd/">Don Lloyd-Jones</a> <a href="/NLKProteomics/">Neil Kelleher</a> ahajournals.org/doi/10.1161/JA…
Science Advances (@scienceadvances) 's Twitter Profile Photo

Scientists propose the Human Proteoform Project—an initiative to describe a complete set of protein forms expressed from the approximately 20,000 genes encoded in the human genome—as a critical next step in disease research. fcld.ly/8820eps

Scientists propose the Human Proteoform Project—an initiative to describe a complete set of protein forms expressed from the approximately 20,000 genes encoded in the human genome—as a critical next step in disease research. fcld.ly/8820eps
Amit Khera (@dramitkhera) 's Twitter Profile Photo

Excellent presentation by Simon Capewell in the Paul Dudley White session at #AHA21 Reminding us of the effectiveness hierarchy for public health- upstream efforts more impactful than downstream- “laws more effective than leaflets” Don Lloyd-Jones Sadiya Khan

Excellent presentation by <a href="/SimonCapewell99/">Simon Capewell</a> in the Paul Dudley White session at #AHA21 Reminding us of the effectiveness hierarchy for public health- upstream efforts more impactful than downstream- “laws more effective than leaflets” <a href="/dmljmd/">Don Lloyd-Jones</a> <a href="/HeartDocSadiya/">Sadiya Khan</a>
John T Wilkins, MD (@jtwilkinsmd) 's Twitter Profile Photo

Outstanding Presidential Address by a tireless advocate for improved #CVH, an incredible mentor, and an inspiration to all of us who are passionate to see reductions in #CVD. Also, he’s just great peeps! Congratulations to Don Lloyd-Jones! #AHA21 #cardiotwitter @american_heart

Outstanding Presidential Address by a tireless advocate for improved #CVH, an incredible mentor, and an inspiration to all of us who are passionate to see reductions in #CVD.  Also, he’s just great peeps! Congratulations to <a href="/dmljmd/">Don Lloyd-Jones</a>! #AHA21 #cardiotwitter 
@american_heart
Benjamin D. Singer (@bsinger007) 's Twitter Profile Photo

#COVID19 numbers are going up in Chicago, and we are preparing at NM Pulmonary and Thoracic Surgery. I talked with Jim Williams CBS Chicago. It's not too late to be fully #vaccinated by Christmas. chicago.cbslocal.com/2021/11/15/chi…

NUCATS Institute (@nucatsinstitute) 's Twitter Profile Photo

New findings by NUCATS Institute members John T Wilkins, MD and Charlesnika T Evans explore COVID-19 reinfection rates. The study also found that having had COVID-19 protects from future infection for only a moderate period of time — bit.ly/3HrEfTI

New findings by <a href="/NUCATSInstitute/">NUCATS Institute</a> members <a href="/JTWilkinsMD/">John T Wilkins, MD</a> and <a href="/CharlesnikaNU/">Charlesnika T Evans</a> explore COVID-19 reinfection rates. The study also found that having had COVID-19 protects from future infection for only a moderate period of time — bit.ly/3HrEfTI
Adam Grant (@adammgrant) 's Twitter Profile Photo

Great minds don’t think alike. They challenge each other to think differently. The people who teach you the most are the ones who share your principles but not your thought processes. Converging values draw you to similar questions. Diverging views introduce you to new answers.

JACC Journals (@jaccjournals) 's Twitter Profile Photo

Tobacco, including primary smoking, secondhand smoke, & use of chewing #tobacco, accounted for 8.71 million deaths & 230 million DALYs in 2019, 36.7% of which were due to #CVD. Learn more from the #JACCGlobalBurdenCVD study jacc.org/doi/10.1016/j.… #JACC #GreatAmericanSmokeout

Tobacco, including primary smoking, secondhand smoke, &amp; use of chewing #tobacco, accounted for 8.71 million deaths &amp; 230 million DALYs in 2019, 36.7% of which were due to #CVD.

Learn more from the #JACCGlobalBurdenCVD study jacc.org/doi/10.1016/j.…

#JACC #GreatAmericanSmokeout
Nathan Kong, MD (@nkong_med) 's Twitter Profile Photo

Incredibly excited to share our paper examining the association between diet quality and incident CV events stratified by BMI in a large pooled cohort! #medtwitter #CardioTwitter AJPC Thankful for all the mentorship! Don Lloyd-Jones John T Wilkins, MD Norrina Allen sciencedirect.com/science/articl…

Northwestern (@northwesternu) 's Twitter Profile Photo

A team of Northwestern scientists have identified proteins that may be key in predicting organ rejection in transplant recipients, helping inform decisions about care. bit.ly/3MjVfhh

fipco (@fipco) 's Twitter Profile Photo

Poster by John T Wilkins, MD et al. at #AHA22 impact of 22y cumulative apoB on ASCVD in CARDIA - similar risk from TRL-P and LDL-P - apoB > 0.80mg/dL per year a cut point of increased CV risk PROMINENT trial: ⬇️TRL-P offset by ⬆️LDL-P (apoB slightly ⬆️) - neutral result on outcomes.

Poster by <a href="/JTWilkinsMD/">John T Wilkins, MD</a> et al. at #AHA22 impact of 22y cumulative apoB on ASCVD in CARDIA
- similar risk from TRL-P and LDL-P
- apoB &gt; 0.80mg/dL per year a cut point of increased CV risk
PROMINENT trial: ⬇️TRL-P offset by ⬆️LDL-P (apoB slightly ⬆️) - neutral result on outcomes.
Erin D. Michos, M.D. (@erinmichos) 's Twitter Profile Photo

Fantastic discussion of the #RESPECTEPA trial by Pam R. Taub, MD❤️💃🏻. #AHA22 AHA Science 👏👏👏 Still a role to consider EPA to address residual risk in secondary prevention patients.

Fantastic discussion of the #RESPECTEPA trial by <a href="/PamTaubMD/">Pam R. Taub, MD❤️💃🏻</a>. #AHA22 <a href="/AHAScience/">AHA Science</a> 👏👏👏 Still a role to consider EPA to address residual risk in secondary prevention patients.